actinic keratosis epidemiology forecast insight

DelveInsight’s ‘Actinic Keratosis–Epidemiology Forecast—2034’ report delivers an in-depth understanding of the Actinic Keratosis, historical and forecasted epidemiology in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Geographies Covered

• The United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2021-2034

Actinic Keratosis Disease Understanding

Actinic Keratosis (AK) referred to as solar keratosis is a rough, scaly patch development on skin from years of intense UV rays sun exposure found often on the face, lips, ears, forearms, scalp, neck, and back of the hands.

Actinic Keratosis are dysplastic proliferations of keratinocytes with potential for malignant transformation. Clinically, Actinic Keratosis are warty growths appearing as macules, papules, or hyper-keratotic plaques with an erythematous background where its etiology involves both individual as well as environmental factors.

Actinic Keratosis are diagnosed clinically in majority of the cases. The diagnosis is done by skin examination and confirmed by skin biopsy if needed. Other non-invasive imaging methods, such as confocal microscopy (CM), are useful in specific situations while doubtful cases of Actinic Keratosis require histo-pathological study to confirm the diagnosis.

Actinic Keratosis has a multitude treatment algorithm. Topical treatments include, Imiquimod, Ingenol mebutate, and fluorouracil. Along with the medications prescribed, ablative-surgical treatments such as cryotherapy, scraping (curettage), and laser therapy are included as therapeutic treatment options for treating Actinic Keratosis patients.

Actinic Keratosis represents a cutaneous condition with an impact on quality of life, and they are an important precursor of cutaneous neoplasias. For this reason, the recognition and prompt treatment of Actinic Keratosis lesions are of extreme importance, since progression of the disease can be prevented.

Actinic Keratosis Epidemiology

The Actinic Keratosis epidemiology division provides insights about the historical and current patient pool along with the forecasted trend for every seven major countries. It helps recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the DelveInsight report also provides the diagnosed patient pool and their trends along with assumptions undertaken.

Key Findings

The disease epidemiology covered in the report provides historical as well as forecasted Actinic Keratosis epidemiology segmented as the Total Diagnosed Prevalence of Actinic Keratosis, Gender-based Prevalence of Actinic Keratosis, and Age-based Prevalence of Actinic Keratosis. The report includes the Prevalent scenario of Actinic Keratosis in 7MM covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2021 to 2034.

Country Wise- Actinic Keratosis Epidemiology

• The epidemiology segment also provides the Actinic Keratosis epidemiology data and findings across the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
• The total prevalent population of Actinic Keratosis associated in 7MM countries was estimated to be 18,524,000 cases in 2020 and expected to increase at a CAGR of 0.54% for the study period, i.e., 2021-2034.
• As per the estimates, United States has the highest prevalent population of Actinic Keratosis in 7MM.
• Among the EU5 countries, Germany had the highest prevalent population of Actinic Keratosis. On the other hand Spain had the lowest prevalent population. In 7MM, Japan had the lowest number of cases, 527,934 cases in 2020.

Scope of the Report

• Actinic Keratosis report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis, and treatment patterns
• Actinic Keratosis Epidemiology Report and Model provide an overview of the risk factors and global trends of Actinic Keratosis in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan)
• The report provides insight into the historical and forecasted patient pool of Actinic Keratosis in the seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan
• The report helps recognize the growth opportunities in the 7MM concerning the patient population
• The report assesses the disease risk and burden and highlights the unmet needs of Actinic Keratosis
• The report provides the segmentation of the Actinic Keratosis epidemiology by prevalent Cases of Actinic Keratosis in 7MM
• The report provides the segmentation of the Actinic Keratosis epidemiology by Total diagnosed Prevalence of Actinic Keratosis, Prevalence of Actinic Keratosis based on Gender specific factors, Age-specific cases of Actinic Keratosis in 7MM

Report Highlights

• 10-year Forecast of Actinic Keratosis epidemiology
• 7MM Coverage
• Total Diagnosed Prevalent Cases of Actinic Keratosis
• Prevalent Cases of Actinic Keratosis based on age-specific Factors
• Gender-specific Prevalence of Actinic Keratosis

KOL Views

We interview KOLs, and SME’s opinion through primary research to fill the data gaps and validate our secondary research. The opinion helps understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.

Key Questions Answered

• What will be the growth opportunities in the 7MM concerning the patient population about Actinic Keratosis?
• What are the Key Findings of Actinic Keratosis epidemiology across 7MM, and which country will have the highest number of patients during the forecast period (2025-2034)?
• What would be the total number of patients with Actinic Keratosis across the 7MM during the forecast period (2025-2034)?
• Among the EU5 countries, which country will have the highest number of patients during the forecast period (2025-2034)?
• At what CAGR the patient population is expected to grow by 7MM during the forecast period (2025-2034)?
• What are the disease risk, burden, and unmet needs of Actinic Keratosis?
• What are the currently available treatments for Actinic Keratosis?

Reasons to buy

The Actinic Keratosis Epidemiology report will allow the user to -

• Develop business strategies by understanding the trends shaping and driving the global Actinic Keratosis market
• Quantify patient populations in the global Actinic Keratosis market to improve product design, pricing, and launch plans
• Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Actinic Keratosis therapeutics in each of the markets covered
• Understand the magnitude of Actinic Keratosis population by its prevalent cases
• Understand the magnitude of Actinic Keratosis population by its clinical manifestation specific cases
• The Actinic Keratosis epidemiology report and model was written and developed by Masters and PhD level epidemiologists
• The Actinic Keratosis Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based on transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over a 10-year forecast period using reputable sources

Key Assessments

• Patient Segmentation
• Disease Risk and Burden
• Risk of disease by the segmentation
• Factors driving growth in a specific patient population